INVESTOR ALERT - TRTC Revenues Stock- Price !! INVESTOR

New Post Public Reply Private Reply Replies (0) Message Board
cb11
INVESTOR ALERT - TRTC Revenues Stock- Price !!

INVESTOR ALARM ( Ver. Sept. 8th )



Bio·Vegetable & Marijuana-Hemp & Green Tech - TRTC Terra Tech Corp. - USA

( Also Medical Field )



This as attempt for by mutual consent and systematical manner

All Here once to be Agree on same Revenues or Stock- Price

Estimate numbers, because everybody just coming- up with

something different is only causing confusions and really

nothing for the GOOD we need to Relay On !





1. Up-Front lets be Agree on the Stock EPS- Ratios & Earning Definition :

- Blue- Chips have an EPS- Ratio of 10 - 20x , OK !

- None Blue- Chips have an EPS- Ratio of 30 - 60x , OK !

- TRTC as No Blue- Chip to apply middle EPS- Ration of 45x !

- TRTC Stocks instead as Issued & Outstanding 88 Mn take 100 Mn !

( OTC Markets Registered Free- Floating Stocks of 48 Mn, same as 2012 )

- Revenue is Not Earning and Earning is the Margin Not Net- Income

and Net- Income Is after Deductions of Any Expenses from Earning

and before of Any Taxes !





2. For Annual Revenues & Earning to calculate we have TRTC Information’s as :



- 5-Acre Production Plant Revenue $ 10 Mn - we apply 9 Mn by Margin 40 % !

( This also as model to sell High- Tech Companies to US Farming Industry. )



- Contracts with NB Plants of 100% & GroRite of 50% From Its Productions !

NB & GroRite Contracts grant TRTC a Royalty of 10% from its Revenues,

the complain send TRTC to increase this to at least 20% since any Agency

Royalty Standards are between 30 - 60% depending on Items- Price Range.

Wondering when the Vande Vredes will be more reasonable to allow the

Royalty of 20%, but resulting we now need to calculate by 10% only.

From NB Plants is known Revenues $ 6 Mn and GroRite $ 4 Mn, by the

Contracts % Resulting to $ 8 Mn, but we take $ 7 Mn to calculate !



- We have now the Starting Q2 of 65 Days Edible Garden Corp. participation

resulting to $ 0,665 Mn, taking this for the Quarters of usually 90 Days

would result to $ 0,920 Mn, but until now we have no TRTC reply of why

its Estimate Q2 for 65 Days of $ 0,8 Mn was not achieved and therefore

it becomes difficult to use the numbers for calculations !


- Florida Project of Revenue $ 800,000 , where TRTC get a Royalty of 15%,

the complain for after the first Business- Year to increase this also to 20%

is made to TRTC, but since there is not yet any TRTC reconfirmation we

need to calculate this by the Royalty of 15% !



- For the Hydroponic Equipments & Accessories & Companies Sales

we have not any reliable Estimate Numbers and need to wait until

the next Version of Investors Presentation.

Therefore at the moment we cannot consider this !



- For TRTC’s Electricity Management Matter we have also No Numbers

until now and therefore cannot consider this !



This Above Points 1. and 2. As Calculation Basis !!





According to Above and to make it a little more simple,

the Calculation Estimates of Revenue, Earnings and

Stock- Price only as from 2014 :



- New 5-Acre Production Plant, Revenue $ 9 Mn, Earning $ 3,6 Mn !



- NB Plants & GroRite Contracts, Revenue $ 7 Mn, Earning $ 0,7 Mn !



- Florida Project, Revenue $ 0,8 Mn, Earning $ 0,12 Mn !

( Here Without New Such Projects TRTC Announced For US Wide ! )



- Hydroponic Equipments & Accessories & Complete Companies Sales also

under Contracts for Edible Garden Products as in Florida, here not considered !



- The TRTC’s Electricity Management Matter, here not considered !



( Here Without Any MJ or Hemp Growing Projects Soon Possible ! )



As Resulting :

2014 Revenue Estimate = $ 16,8 Mn

2014 Earning Estimate = $ 4,42 Mn



TRTC Stock- Price = $ 1,99 at for example 100 Mn Stocks by EPS- Ratio 45x !!

This within the first 6 Months of 2014, depending on TRTC Progress

Information’s and the resulting Investors Reactions !!



At during 2012 until Q1 2013, the Monthly Money Net- Loss

was at $ 0,5 Mn and this now by 50% Less has improved !.

At Same Rate TRTC Will Be Writing Black- Profit Numbers

Already As From Within November 2013 !!


3. If TRTC by the US Fed. would be allowed to grow MJ or TRTC does

Grow the Gene Manipulated CBD Hemp with ZERO THC as already by

the US Senate as Industrial Agricultural Product Is US Wide Legalized,

it compare the Bio·Vegetable & Herbs could provide a 7 - 10x Higher

Profit- Margin resulting the Stock- Price of $ 1,99 to increase 6 - 8x !!



To use possibly Morphine- Based Medication with Huge- Side- Effects only

for Last Days of Life, because CBD can replace over 90 % of Morphine

Applications !

For TRTC because there is no other same US company existing it means

also, if GW Pharmaceuticals owned by the Big Companies Consortium of

worldwide annual Revenues $ 160 Bn is deciding to have Production of

CBD Sativex also in the US as well for Latin America Markets, it could by

TRTC in US get the Gene Manipulated CBD Hemp produced Hydroponically

Free Of Very Toxic Pesticides, instead now just everything Europe Made !!



Depending on US MJ Laws, TRTC has the Big Potential to become

„King of Marijuana“ because has the capacity to produce the MMJ

in the Best Med. Bio-Quality for the complete US Demand without

Very Toxic Pesticides as by any other much smaller producers !!

This By TRTC‘s Office for MJ & CBD Marketing In Washington !

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 530

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 347

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 607

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 518

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading

Top 5 Most Recently Viewed Articles

Westlake Chemical Partners Schedules Q4 and Year-End Call

Updated Category News Views 158

Westlake Chemical Partners to Announce Earnings Soon Westlake Chemical Partners (NYSE: WLKP), based in Houston, is preparing to release its earnings report for the fourth quarter and full year 2024. This significant announcement is eagerly anticipated by investors and industry analysts alike. The earnings report is scheduled to be released prior to the market opening on a...

Continue Reading
Wabtec's Bold Move: Acquiring Evident's Tech Division

Updated Category News Views 144

Wabtec's Strategic Acquisition of Evident's Inspection Technologies Wabtec Corp, a leader in heavy industrial parts manufacturing, has made headlines with its recent decision to acquire the inspection technologies division of Evident for an impressive $1.78 billion. This acquisition reflects Wabtec's strategy to enhance its portfolio and strengthen its position within the...

Continue Reading
Insight into WisdomTree's Latest Fund Valuations

Updated Category News Views 184

Understanding Net Asset Values in ETFs Investors often seek knowledge about the net asset values (NAVs) of Exchange Traded Funds (ETFs), which play a critical role in determining how funds are valued and traded in the market. For instance, WisdomTree Issuer plc regularly offers updates concerning its funds, revealing the intricate details behind price fluctuations and...

Continue Reading
Investigation Announced Into Electronic Systems Technology, Inc.

Updated Category News Views 239

Investigation of Electronic Systems Technology, Inc. In a noteworthy development, the M&A Class Action Firm has announced an investigation into Electronic Systems Technology, Inc. (OTCMKTS: ELST). This firm, recognized as a top competitor in the 2024 ISS Securities Class Action Services Report, is dedicated to protecting shareholder interests. The firm, led by renowned...

Continue Reading
Fusion CBD Products Partners with Major League Baseball Teams

Updated Category News Views 291

Fusion CBD Products and Major League Baseball: A Growing Partnership Team sponsorship opportunities expand as the league embraces CBD's advantages. As the Major League Baseball (MLB) season unfolds, many players are facing injuries from early training sessions and games. Notable players like Heliot Ramos of the San Francisco Giants and Erik Miller have recently dealt with...

Continue Reading